TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/19/2026ACC: 0001712276-26-000005
Officer· Chief Financial Officer
Since Feb 2026
-25.02K
Net shares
Net seller
$76.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
25.02K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−25.02K
Price / share
$3.04
Trade value
$76.05K
% of position
2.2%
5/15/2026
1.13M→1.11M
Total
Net shares
−25.02K
Net value
-$76.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/15/2026 | F · Tax Withholding | −25.02K | $3.04 | $76.05K | 2.2% | 1.13M | 1.11M |
| Total | −25.02K | -$76.05K | ||||||
Derivative Transactions0
No derivative transactions reported